Six-month Performance of Meniscal Wall Infiltration Under Ultrasound to Treat Stable Degenerative Meniscal Injuries.

• Status: Not yet recruiting
• Trial end date: 2024-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The main hypothesis of the study is that in situ infiltration of the meniscal lesion would provide patients with lasting and greater relief than intra-articular infiltration. A statistically significant difference would be if the Lysholm score of the meniscal wall group at 3 months is 9.5 points higher than that of the intra-articular infiltration group.

The aim is to evaluate the effectiveness of meniscal wall infiltration under ultrasound in the treatment of stable degenerative meniscal lesions versus intra-articular infiltration (Gold standard) at 3 months by Lysholm's algo-functional score.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Hospitalier Universitaire de Nīmes

Criteria

Inclusion Criteria:

• Patients with a symptomatic meniscal lesion of a degenerative nature, isolated or associated with early osteoarthritis or chondropathy (Ahlbach stages 1 and 2).

• Indication for peri-meniscal infiltration under ultrasound control of the knee for a clinically stable degenerative meniscal lesion confirmed by MRI and radiography.

• Patient who has given free and informed consent.

• Patient who has signed the consent form.

• Patient affiliated or beneficiary of a health insurance plan.

• Adult patient (≥18 years of age).

Exclusion Criteria:

• No iconographic evidence of meniscal injury.

• Associated lesions of the central pivot of the knee.

• Knee pain of osteoarthritic origin strongly suggested by the clinic associated with an advanced radiological stage of osteoarthritis (Ahlbach stages 3 and 4).

• Presence of a skin lesion at the infiltration sites.

• Suspected soft tissue or joint infection.

• Patient participating in research involving human subjects defined as Category 1.

• Patient in an exclusion period as determined by another study.

• Patient under court protection, guardianship or trusteeship.

• Patient unable to give consent.

• Patient for whom it is impossible to give informed information.

• Pregnant, parturient or breastfeeding women.